diabetic retinopathy

News

Bayer returns to M&A with $2.45bn Perfuse Therapeutics deal

Bayer has agreed terms for its first biopharma takeover in years, paying $300m upfront for Perfuse and its novel drug implant for eye diseases.

News

AI platform in use in a doctor's surgery

Platform tests commercial algorithms for NHS use for bias

A platform that can test whether AI algorithms developed for NHS applications are fit for purpose and free of bias has shown its value in a new study.

News

Valo Health chief executive Brian Alexander, who is also CEO-Partner of Flagship Pioneering

Flagship-backed AI startup Valo shelves eye disease drug

Valo Health will no longer develop its ROCK1/2 inhibitor for diabetic retinopathy on its own after a trial readout but will seek to partner the drug.

Patients

The burden of diabetic vision loss in the West

Vision loss associated with diabetes is one of the more prevalent and growing healthcare burdens in the Western world.

News

Cholesterol drug could find new role in diabetic eye disease

A decades-old drug used to lower cholesterol levels in the blood has been shown to reduce the progression of vision-robbing retinopathy in people with diabetes.

News

PolyPhotonix raises $10m to trial sleep mask for diabetic ey...

The UK company behind a sleep mask that aims to treat sight-robbing complications of diabetes has secured $10 million in funding that will be used to run trials of the medical device.

Bayer returns to M&A with $2.45bn Perfuse Therapeutics deal

Platform tests commercial algorithms for NHS use for bias

Flagship-backed AI startup Valo shelves eye disease drug

The burden of diabetic vision loss in the West

Cholesterol drug could find new role in diabetic eye disease

PolyPhotonix raises $10m to trial sleep mask for diabetic ey...

OpenBind unveils its first AI model for drug discovery

Discover a new era of healthcare panel engagement: Grounded ...

diabetic retinopathy

Editor's Picks